KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Net Cash Flow (2016 - 2025)

Quest Diagnostics' Net Cash Flow history spans 17 years, with the latest figure at -$13.0 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 93.75% year-over-year to -$13.0 million; the TTM value through Dec 2025 reached -$133.0 million, down 2.31%, while the annual FY2025 figure was -$133.0 million, 2.31% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$13.0 million at Quest Diagnostics, down from $115.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $543.0 million in Q4 2023 and bottomed at -$670.0 million in Q2 2021.
  • The 5-year median for Net Cash Flow is -$69.5 million (2022), against an average of -$36.8 million.
  • The largest annual shift saw Net Cash Flow crashed 322.22% in 2022 before it surged 2800.0% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at -$115.0 million in 2021, then plummeted by 234.78% to -$385.0 million in 2022, then soared by 241.04% to $543.0 million in 2023, then crashed by 138.31% to -$208.0 million in 2024, then surged by 93.75% to -$13.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Net Cash Flow are -$13.0 million (Q4 2025), $115.0 million (Q3 2025), and $127.0 million (Q2 2025).